Dr. Hönle AG / DE0005157101

Gilching (IRW-Press/07.08.2025) - * Hönle Group achieves sales of €69.8 million (-3%) in the first nine months of 2025 in a difficult market environment * EBITDA at €3.6 million (-12%)

* Operating cash flow of €3.7 million generated

Geopolitical uncertainties continue to impact the investment climate. This impacted the Hönle Group's business performance in the first nine months of the 2024/25 financial year. The Adhesive Systems business unit was particularly affected, while the Curing business unit remained robust despite the discontinuation of unprofitable product lines that were not part of its core business. The disinfection business area using environmentally friendly UV technology performed well. Overall, sales declined from T€72,056 in the previous year to T€69,809 in the current financial year.

Savings in logistics, marketing, and consulting services contributed to a reduction in other operating expenses by €921 thousand to €10,571 thousand. Earnings before interest, taxes, and depreciation (EBITDA) amounted to €3,554 thousand after nine months (previous year: €4,023 thousand). After depreciation and amortization, the operating result (EBIT) was -€554 thousand (previous year: -€118 thousand), and after interest and taxes, the result for the period was -€1,320 thousand (previous year: -€946 thousand).

outlook

Hardening Business Unit

In the Curing business unit, Hönle has defined curing systems for packaging printing, coatings on two- and three-dimensional objects, technical films, and labels as strategic focus areas. Increased print quality requirements and high demands on functional surface coatings, as well as the growing need for integrated process control, offer good growth opportunities for UV, UV-LED, and IR systems in many industrial application areas.

In close coordination with key customers and their requirements, Hoenle continuously implements innovations in curing solutions processes and has recently secured several attractive projects with industrial customers. One example of these innovations is the recently launched high-precision UV dose measurement system UV Scan MACS for optimized process control. Hoenle has also entered into a cooperation with a manufacturer of paints and coating materials to jointly develop and market optimal solutions for a wide range of applications.

Through innovative process solutions for industrial hardening applications and continuous profit optimization in the OEM and after-sales sectors, the Management Board expects increasing sales and earnings contributions in the coming years.

Business Unit Adhesive Systems

Hoenle is continuously expanding its product range of adhesives for its strategic focus areas of electronics, medical, and optics, increasingly focusing on UV-curing adhesives and the optimized use of UV curing systems, which offer advantages in terms of heat input and processing speed. In close collaboration with customers, optimal solutions for the respective application areas are currently being developed in several promising projects.

Despite the current reluctance of customers in the automotive sector, the Management Board expects significantly increased sales in the coming years, particularly in Asia and North America. In addition to increasing sales, improvements in internal processes and a regular streamlining of the product range should contribute to a sustainable improvement in results.

Disinfection Business Unit

In the Disinfection business unit, Hoenle offers the complete range of services for the disinfection process, including low-pressure lamps, medium-pressure lamps, LEDs, and pulsed UV light, along with microbiological services. In addition to established fields of application such as ballast water disinfection, new applications are continuously being developed. The qualification of components for the treatment of ultrapure water for customers in the semiconductor industry is progressing and, as planned, generating initial sales this fiscal year. Expressions of interest for equipping additional semiconductor plants have already been received. Sales markets in the food industry are also developing positively, where, in addition to the wide range of different disinfection qualities, regular quality control using bioindicators is meeting strong demand.

Disinfection with ultraviolet radiation is reliable, efficient and environmentally friendly and, according to the Management Board, will continue to grow in the coming years both in existing markets and in new application areas, particularly in Asia and North America.

Overall statement on future business development

As communicated in the announcement of August 5, 2025, the Management Board expects the Hönle Group to generate sales of between €92 million and €94 million in the 2024/25 financial year (previous year: €98.7 million). Due to the cost-cutting measures initiated, it expects operating earnings before interest, taxes, depreciation and amortization (EBITDA) of between €5 million and €6 million (adjusted EBITDA: €5.5 million) despite the lower sales level.

Further information

Q3 2024/25 announcement: https://www.hoenle.de/investoren/report

About Hönle

Dr. Hönle AG is a publicly listed technology company headquartered in Gilching, Germany. With 600 employees, the Hönle Group develops innovative solutions with a focus on UV technology for a wide range of industrial applications. One business area includes the development and distribution of industrial adhesives and adhesive curing equipment. Furthermore, systems for drying ink and varnish for the printing and coating industry are manufactured. Another business area focuses on the environmentally friendly disinfection of water, air, and surfaces. The Hönle Group supplies technology and global market leaders worldwide and is represented in over 20 countries with its own companies and partner companies.

(End)

Sender: Dr. Hönle AG Address: Nicolaus-Otto-Str. 2, 82205 Gilching Country: Germany Contact: Peter Weinert Tel.: +49 8105 2083 173 Email: [email protected]

Website: www.hoenle.de

ISIN(s): DE0005157101 (share) Stock exchanges: Regulated Market in Frankfurt; Open Market in Düsseldorf, Open Market in Hamburg, Open Market in Hanover, Open Market in Munich, Open Market in Stuttgart; Open Market in Berlin, Tradegate